Riverpark Capital Management LLC purchased a new position in Iqvia Holdings Inc (NYSE:IQV) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 87,130 shares of the medical research company’s stock, valued at approximately $8,530,000.
A number of other large investors have also bought and sold shares of the stock. BlackRock Inc. acquired a new stake in shares of Iqvia during the fourth quarter worth approximately $942,532,000. Longview Partners Guernsey LTD acquired a new stake in shares of Iqvia in the fourth quarter valued at approximately $927,548,000. Jackson Square Partners LLC acquired a new stake in shares of Iqvia in the fourth quarter valued at approximately $464,053,000. Farallon Capital Management LLC acquired a new stake in shares of Iqvia in the fourth quarter valued at approximately $290,072,000. Finally, Alliancebernstein L.P. acquired a new stake in shares of Iqvia in the fourth quarter valued at approximately $253,128,000. 92.34% of the stock is owned by hedge funds and other institutional investors.
Iqvia Holdings Inc (IQV) opened at $105.60 on Monday. The firm has a market cap of $21,993.32, a price-to-earnings ratio of 22.91, a PEG ratio of 2.70 and a beta of 0.64. Iqvia Holdings Inc has a 52-week low of $76.80 and a 52-week high of $110.67. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 1.21.
In other Iqvia news, Director Michael J. Evanisko sold 816 shares of Iqvia stock in a transaction on Monday, March 5th. The shares were sold at an average price of $100.00, for a total value of $81,600.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider James H. Erlinger III sold 10,000 shares of Iqvia stock in a transaction on Wednesday, January 17th. The shares were sold at an average price of $99.97, for a total transaction of $999,700.00. The disclosure for this sale can be found here. Insiders sold a total of 30,816 shares of company stock worth $3,093,400 over the last ninety days. 6.00% of the stock is currently owned by insiders.
A number of equities analysts have issued reports on IQV shares. TheStreet raised shares of Iqvia from a “c+” rating to a “b” rating in a research note on Wednesday, December 13th. Mitsubishi UFJ Financial Group started coverage on shares of Iqvia in a research note on Friday, December 15th. They issued a “neutral” rating and a $112.00 price objective on the stock. Zacks Investment Research raised shares of Iqvia from a “hold” rating to a “buy” rating and set a $112.00 price objective on the stock in a research note on Thursday, January 18th. Evercore ISI started coverage on shares of Iqvia in a research note on Thursday, January 18th. They issued an “outperform” rating and a $112.00 price objective on the stock. Finally, SunTrust Banks reaffirmed a “hold” rating and issued a $110.00 price objective on shares of Iqvia in a research note on Monday, January 22nd. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $110.02.
COPYRIGHT VIOLATION NOTICE: “Riverpark Capital Management LLC Takes Position in Iqvia Holdings Inc (IQV)” was reported by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/03/12/riverpark-capital-management-llc-takes-position-in-iqvia-holdings-inc-iqv.html.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.